U.S. markets close in 5 hours 48 minutes
  • S&P 500

    4,687.21
    +0.46 (+0.01%)
     
  • Dow 30

    35,762.47
    +43.04 (+0.12%)
     
  • Nasdaq

    15,658.46
    -28.45 (-0.18%)
     
  • Russell 2000

    2,261.47
    +7.68 (+0.34%)
     
  • Crude Oil

    71.98
    -0.07 (-0.10%)
     
  • Gold

    1,785.20
    +0.50 (+0.03%)
     
  • Silver

    22.46
    -0.06 (-0.28%)
     
  • EUR/USD

    1.1321
    +0.0048 (+0.43%)
     
  • 10-Yr Bond

    1.4990
    +0.0190 (+1.28%)
     
  • GBP/USD

    1.3191
    -0.0051 (-0.38%)
     
  • USD/JPY

    113.8570
    +0.3170 (+0.28%)
     
  • BTC-USD

    50,893.12
    -661.99 (-1.28%)
     
  • CMC Crypto 200

    1,325.91
    +20.79 (+1.59%)
     
  • FTSE 100

    7,352.87
    +12.97 (+0.18%)
     
  • Nikkei 225

    28,860.62
    +405.02 (+1.42%)
     

Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer. What It Means for the Stocks.

·3 min read
Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer. What It Means for the Stocks.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The CDC's influential vaccines advisory committee recommended both Pfizer and Merck’s new pneumococcal vaccines for older adults, surprising analysts.